Phase 4 Polyneuropathy Clinical Trials

3 recruitingPhase 4

What is a Phase 4 trial?

Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.

Showing 1–3 of 3 trials

Recruiting

Phase 4

Two Dose Levels of Privigen in Pediatric CIDP

Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

CSL Behring30 enrolled9 locationsNCT03684018

Recruiting

Phase 4

To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy

Transthyretin Amyloid Polyneuropathy

Qilu Pharmaceutical Co., Ltd.15 enrolled1 locationNCT06940336

Recruiting

Phase 4

Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)

CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

University of Aarhus60 enrolled4 locationsNCT04589299